A double-blind, placebo-controlled study of escitalopram in the prevention of depression in patients with acute coronary syndrome

Trial Profile

A double-blind, placebo-controlled study of escitalopram in the prevention of depression in patients with acute coronary syndrome

Completed
Phase of Trial: Phase IV

Latest Information Update: 19 Jul 2012

At a glance

  • Drugs Escitalopram (Primary)
  • Indications Depression
  • Focus Therapeutic Use
  • Acronyms DECARD
  • Most Recent Events

    • 01 Jan 2012 Results published in the Journal of Psychosomatic Research.
    • 07 Apr 2009 New source identified and integrated (Trials 10: 20 7 Apr 2009).
    • 30 Dec 2008 Planned number of patients changed from 266 to 240 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top